Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
https://www.globenewswire.com/news-release/2022/01/11/2364694/0/en/ASLAN-Pharmaceuticals-to-Present-Additional-Data-From-Aslan004-Proof-Of-Concept-Study-at-Two-Upcoming-Winter-Dermatology-Conferences.html
Jan 11, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next